πŸ‡ΊπŸ‡Έ FDA
Patent

US 10888618

Method of treating cancer

granted A61KA61K2800/30A61K2800/34

Quick answer

US patent 10888618 (Method of treating cancer) held by Intensity Therapeutics, Inc. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Intensity Therapeutics, Inc.
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2800/30, A61K2800/34, A61K2800/524, A61K31/192